Germany’s 2024 Tissue Supply Report Highlights Transparency and Vital Medical Procedures
Table of Contents
A new report from the Paul Ehrlich Institute (PEI) underscores the critical role of human tissue supply in Germany, revealing detailed data on the collection, processing, and transplantation of vital tissues in 2024. The report, based on data submitted by hundreds of facilities, provides a crucial foundation for ensuring both the transparency and traceability of medical care reliant on these life-saving resources.
Comprehensive Data on Tissue Activities
The PEI, Germany’s Federal Institute for Vaccines and Biomedical Drugs, receives annual reports from tissue facilities – defined as any organization conducting authorized activities with tissues, tissue preparations, or related stem cells – as mandated by Section 8d of the Transplantation Act (TPG). These reports detail all aspects of tissue handling, from initial extraction to final use, including import and export activities. According to the PEI, this data is published anonymously each year to maintain patient privacy while fostering public trust.
764 Facilities Report Tissue Data for 2024
In 2024, a total of 764 clinics, treatment centers, and specialized medical practices contributed data to the PEI’s report. The collected information encompasses a wide range of tissue types, including corneas, heart valves, and skin tissue, among others. This broad scope highlights the diverse applications of human tissue in modern medicine.
Corneal Transplants: Restoring Sight in Germany
The report specifically highlights the significant number of corneal transplants performed in Germany during 2024. A total of 15,668 corneas were removed, and 11,431 were successfully transplanted. This procedure offers a life-changing solution for individuals experiencing vision loss due to corneal clouding or injury, potentially restoring their sight.
Ensuring Quality and Transparency in Tissue Supply
The PEI emphasizes that the annual report plays a vital role in maintaining the quality and reliability of Germany’s tissue supply. “The report from the Paul Ehrlich Institute on the reports according to § 8d TPG makes an important contribution to transparency, planning and quality assurance in the area of tissue supply in Germany,” a senior official stated. This commitment to transparency is essential for building confidence in the medical system and ensuring patients receive the best possible care.
The detailed data collected and published by the PEI serves as a valuable resource for healthcare professionals, researchers, and policymakers alike, supporting informed decision-making and continuous improvement in the field of tissue medicine.
